192 related articles for article (PubMed ID: 28802906)
1. Pathways towards indolent B-cell lymphoma - Etiology and therapeutic strategies.
van den Brand M; Scheijen B; Hess CJ; van Krieken JHJ; Groenen PJTA
Blood Rev; 2017 Nov; 31(6):426-435. PubMed ID: 28802906
[TBL] [Abstract][Full Text] [Related]
2. Indolent lymphomas of mature B lymphocytes.
Kurtin PJ
Hematol Oncol Clin North Am; 2009 Aug; 23(4):769-90. PubMed ID: 19577169
[TBL] [Abstract][Full Text] [Related]
3. Genetic landscape and deregulated pathways in B-cell lymphoid malignancies.
Rosenquist R; Beà S; Du MQ; Nadel B; Pan-Hammarström Q
J Intern Med; 2017 Nov; 282(5):371-394. PubMed ID: 28631441
[TBL] [Abstract][Full Text] [Related]
4. [Biology and treatment of indolent lymphomas: follicular lymphoma and marginal zone B-cell lymphoma].
Nishikori M
Rinsho Ketsueki; 2009 Oct; 50(10):1332-41. PubMed ID: 19915340
[No Abstract] [Full Text] [Related]
5. Indolent lymphomas in the pediatric population: follicular lymphoma, IRF4/MUM1+ lymphoma, nodal marginal zone lymphoma and chronic lymphocytic leukemia.
Quintanilla-Martinez L; Sander B; Chan JK; Xerri L; Ott G; Campo E; Swerdlow SH
Virchows Arch; 2016 Feb; 468(2):141-57. PubMed ID: 26416032
[TBL] [Abstract][Full Text] [Related]
6. [Application of gene expression profiling in molecular classification, prognosis and therapy of B-cell lymphoma].
Mao ZR; Zhou R; Zhang XX; Mueller-Hermelink Hk; Rosenwald A
Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):785-9. PubMed ID: 20079025
[No Abstract] [Full Text] [Related]
7. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2015 Aug; 90(8):739-45. PubMed ID: 26103436
[TBL] [Abstract][Full Text] [Related]
8. Transformation of marginal zone lymphoma (and association with other lymphomas).
Casulo C; Friedberg J
Best Pract Res Clin Haematol; 2017; 30(1-2):131-138. PubMed ID: 28288708
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic advances for indolent lymphomas].
Ogura M
Nihon Rinsho; 2000 Mar; 58(3):682-94. PubMed ID: 10741147
[TBL] [Abstract][Full Text] [Related]
10. Etiology and therapy of Helicobacter pylori-associated gastric lymphomas.
Wündisch T; Kim TD; Thiede C; Morgner A; Alpen B; Stolte M; Neubauer A
Ann Hematol; 2003 Sep; 82(9):535-45. PubMed ID: 12845479
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology, pathology and treatment of non-follicular indolent lymphomas.
Landgren O; Tilly H
Leuk Lymphoma; 2008; 49 Suppl 1():35-42. PubMed ID: 18821431
[TBL] [Abstract][Full Text] [Related]
12. Are we nearing an era of chemotherapy-free management of indolent lymphoma?
Bachy E; Salles G
Clin Cancer Res; 2014 Oct; 20(20):5226-39. PubMed ID: 25320372
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 expression in B-cell lymphomas.
Gladkikh A; Potashnikova D; Korneva E; Khudoleeva O; Vorobjev I
Exp Hematol; 2010 Nov; 38(11):1047-57. PubMed ID: 20727381
[TBL] [Abstract][Full Text] [Related]
14. Learning from the failures of drug discovery in B-cell non-Hodgkin lymphomas and perspectives for the future: chronic lymphocytic leukemia and diffuse large B-cell lymphoma as two ends of a spectrum in drug development.
Kubuschok B; Trepel M
Expert Opin Drug Discov; 2017 Jul; 12(7):733-745. PubMed ID: 28494631
[TBL] [Abstract][Full Text] [Related]
15. Pediatric-Type Indolent B-Cell Lymphomas With Overlapping Clinical, Pathologic, and Genetic Features.
Lim S; Lim KY; Koh J; Bae JM; Yun H; Lee C; Kim YA; Paik JH; Jeon YK
Am J Surg Pathol; 2022 Oct; 46(10):1397-1406. PubMed ID: 35834399
[TBL] [Abstract][Full Text] [Related]
16. The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing.
Swerdlow SH; Kuzu I; Dogan A; Dirnhofer S; Chan JK; Sander B; Ott G; Xerri L; Quintanilla-Martinez L; Campo E
Virchows Arch; 2016 Mar; 468(3):259-75. PubMed ID: 26454445
[TBL] [Abstract][Full Text] [Related]
17. Premalignant cell dynamics in indolent B-cell malignancies.
Milpied P; Nadel B; Roulland S
Curr Opin Hematol; 2015 Jul; 22(4):388-96. PubMed ID: 26049761
[TBL] [Abstract][Full Text] [Related]
18. NCCN: Non-Hodgkin's lymphoma.
Zelenetz AD; Hoppe RT;
Cancer Control; 2001; 8(6 Suppl 2):102-13. PubMed ID: 11760551
[No Abstract] [Full Text] [Related]
19. Indolent B-cell non-Hodgkin's lymphomas.
Seng JE; Peterson BA
Oncology (Williston Park); 1997 Dec; 11(12):1883-94, 1987; discussion 1901-2, 1. PubMed ID: 9436191
[TBL] [Abstract][Full Text] [Related]
20. Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections.
Specht K; Kremer M; Müller U; Dirnhofer S; Rosemann M; Höfler H; Quintanilla-Martinez L; Fend F
Clin Cancer Res; 2002 Sep; 8(9):2902-11. PubMed ID: 12231535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]